Latest TTNP reports update at 2024-05-15: 2024-Q12023-Q42023-Q1
Titan Pharmaceuticals logo
Titan Pharmaceuticals TTNP
$ 6.82 0.0%

Titan Pharmaceuticals Balance Sheet 2011-2024 | TTNP

Annual Balance Sheet Titan Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-2.75 M -5.74 M -4.94 M -782 K -4.98 M -938 K -14 M -7.86 M -15.5 M -11.8 M -6.24 M 6.85 M

Long Term Debt

- 65 K 187 K 327 K 4.02 M 3.79 M 3.58 M - - - - 9.36 M 12.3 M

Long Term Debt Current

65 K 122 K 112 K 150 K 272 K 527 K 3 M - - - - 2.5 M -

Total Non Current Liabilities

- - - 327 K 4.49 M 3.81 M 3.58 M 619 K 1.44 M 5.58 M 1.82 M 26.6 M 25.2 M

Total Current Liabilities

1.44 M 2.63 M 2.67 M 4.22 M 3.6 M 3.45 M 4.46 M 4.86 M 4.85 M 6.66 M 10.8 M 21.4 M 5.12 M

Total Liabilities

1.44 M 2.7 M 2.86 M 4.56 M 8.09 M 7.26 M 8.05 M 5.48 M 6.3 M 12.2 M 12.7 M 48 M 30.3 M

Deferred Revenue

- - - - - 313 K - - - 1.67 M 5.32 M 14.4 M -

Retained Earnings

-392 M -386 M -376 M - -349 M -333 M -323 M -309 M -314 M -303 M -300 M -310 M -295 M

Total Assets

8.09 M 4.06 M 7.99 M 8.09 M 9.52 M 14.1 M 8.9 M 18.7 M 13.3 M 20.9 M 18.4 M 24.8 M 10.2 M

Cash and Cash Equivalents

6.76 M 2.94 M 6.04 M 5.41 M 5.22 M 9.3 M 7.52 M 14 M 7.86 M 15.5 M 11.8 M 18.1 M 5.41 M

Book Value

6.64 M 1.36 M 5.14 M 3.53 M 1.43 M 6.83 M 857 K 13.2 M 6.99 M 8.61 M 5.76 M -23.1 M -20.1 M

Total Shareholders Equity

6.64 M 1.36 M 5.14 M 3.53 M 1.43 M 6.83 M 857 K 13.2 M 6.99 M 8.61 M 5.76 M -23.1 M -20.1 M

All numbers in USD currency

Quarterly Balance Sheet Titan Pharmaceuticals

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - 33 K 65 K 96 K 128 K 158 K 187 K - - 88 K 332 K 332 K 332 K 332 K 4.02 M 4.02 M 4.02 M 4.02 M 3.79 M 3.79 M 3.79 M 3.79 M 3.58 M 3.58 M 3.58 M 3.58 M - - - - - - - - - - - - - - - - 9.36 M 9.36 M 9.36 M 9.36 M 12.3 M 12.3 M 12.3 M 12.3 M

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

559 K 1.44 M 1.87 M 1.85 M 2.48 M 2.7 M 2.73 M 2.65 M 2.44 M 2.86 M 2.14 M 2.76 M 3.84 M 4.56 M 4.56 M 4.56 M 4.56 M 8.09 M 8.09 M 8.09 M 8.09 M 7.26 M 7.26 M 7.26 M 7.26 M 8.05 M 8.05 M 8.05 M 8.05 M 5.48 M 5.48 M 5.48 M 5.48 M 6.3 M 6.3 M 6.3 M 6.3 M 12.2 M 12.2 M 12.2 M 12.2 M 12.7 M 12.7 M 12.7 M 12.7 M 48 M 48 M 48 M 48 M 30.3 M 30.3 M 30.3 M 30.3 M

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - 313 K 626 K 939 K 313 K - - - - - - - - - - - 760 K 1.67 M 1.67 M 1.67 M 1.67 M 5.32 M 5.32 M 5.32 M 5.32 M 14.4 M 14.4 M 14.4 M 14.4 M - - - -

Retained Earnings

-393 M -392 M -390 M -390 M -388 M -386 M -384 M -381 M -379 M -376 M -374 M -372 M -370 M -367 M -367 M -367 M -367 M -349 M -349 M -349 M -349 M -333 M -333 M -333 M -333 M -323 M -323 M -323 M -323 M -309 M -309 M -309 M -309 M -314 M -314 M -314 M -314 M -303 M -303 M -303 M -303 M -300 M -300 M -300 M -300 M -310 M -310 M -310 M -310 M -295 M -295 M -295 M -295 M

Total Assets

6.65 M 8.09 M 10 M 812 K 2.17 M 4.06 M 6.28 M 8.32 M 10.3 M 7.99 M 9.64 M 11.5 M 13.8 M 8.09 M 8.09 M 8.09 M 8.09 M 9.52 M 9.52 M 9.52 M 9.52 M 14.1 M 14.1 M 14.1 M 14.1 M 8.9 M 8.9 M 8.9 M 8.9 M 18.7 M 18.7 M 18.7 M 18.7 M 13.3 M 13.3 M 13.3 M 13.3 M 20.9 M 20.9 M 20.9 M 20.9 M 18.4 M 18.4 M 18.4 M 18.4 M 24.8 M 24.8 M 24.8 M 24.8 M 10.2 M 10.2 M 10.2 M 10.2 M

Cash and Cash Equivalents

6.16 M 6.76 M 8.1 M 105 K 1.14 M 2.94 M 4.45 M 6.42 M 8.14 M 6.04 M 7.42 M 9.68 M 11.6 M 5.41 M 5.41 M 5.41 M 5.41 M 5.22 M 5.22 M 5.22 M 5.22 M 9.3 M 9.3 M 9.3 M 9.3 M 7.52 M 7.52 M 7.52 M 7.52 M 14 M 14 M 14 M 14 M 7.86 M 7.86 M 7.86 M 7.86 M 15.5 M 15.5 M 15.5 M 15.5 M 11.8 M 11.8 M 11.8 M 11.8 M 18.1 M 18.1 M 18.1 M 18.1 M 5.41 M 5.41 M 5.41 M 5.41 M

Book Value

6.09 M 6.64 M 8.13 M -1.03 M -312 K 1.36 M 3.55 M 5.67 M 7.88 M 5.14 M 7.5 M 8.75 M 9.98 M 3.53 M 3.53 M 3.53 M 3.53 M 1.43 M 1.43 M 1.43 M 1.43 M 6.83 M 6.83 M 6.83 M 6.83 M 857 K 857 K 857 K 857 K 13.2 M 13.2 M 13.2 M 13.2 M 6.99 M 6.99 M 6.99 M 6.99 M 8.61 M 8.61 M 8.61 M 8.61 M 5.76 M 5.76 M 5.76 M 5.76 M -23.1 M -23.1 M -23.1 M -23.1 M -20.1 M -20.1 M -20.1 M -20.1 M

Total Shareholders Equity

6.09 M 6.64 M 8.13 M -1.03 M -312 K 1.36 M 3.55 M 5.67 M 7.88 M 5.14 M 7.5 M 8.75 M 9.98 M 3.53 M 3.53 M 3.53 M 3.53 M 1.43 M 1.43 M 1.43 M 1.43 M 6.83 M 6.83 M 6.83 M 6.83 M 857 K 857 K 857 K 857 K 13.2 M 13.2 M 13.2 M 13.2 M 6.99 M 6.99 M 6.99 M 6.99 M 8.61 M 8.61 M 8.61 M 8.61 M 5.76 M 5.76 M 5.76 M 5.76 M -23.1 M -23.1 M -23.1 M -23.1 M -20.1 M -20.1 M -20.1 M -20.1 M

All numbers in USD currency